Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon

Vanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies in combating the virus.
Researchers at Vanderbilt University Medical Center have identified human monoclonal antibodies that target influenza B, a major public health concern that primarily impacts children, the elderly, and those with weakened immune systems.

Seasonal flu vaccines cover influenza B and the more common influenza A but do not stimulate the broadest possible range of immune responses against both viruses. In addition, people whose immune systems have been weakened by age or illness may not respond effectively to the flu shot.